PepGen is empowering nucleic acid therapeutics to go the distance.
Pepgen has raised $115.0M in total funding. The most recent round was Post-IPO Equity. The last funding was announced in September 2025.
Pepgen's investors include RA Capital Management, Samsara BioCapital, Janus Henderson Investors, Perceptive Advisors, Oxford Science Enterprises.
Pepgen is headquartered in Oxford, United Kingdom.
PepGen is empowering nucleic acid therapeutics to go the distance.
Pepgen is at the Post-IPO Equity stage.
Free to use in articles, research, and reference works. Stable URL — will not change. Data on this page last updated .
"Pepgen — Funding & Investors." VCBacked, September 24, 2025, https://www.vcbacked.co/company/pepgen. Accessed November 11, 2026.
VCBacked. (2025). Pepgen — Funding & Investors. Retrieved November 11, 2026, from https://www.vcbacked.co/company/pepgen
{{cite web |title=Pepgen — Funding & Investors |url=https://www.vcbacked.co/company/pepgen |website=VCBacked |access-date=November 11, 2026}}Profile data sourced and verified per the VCbacked methodology · Last funding round dated
Work at Pepgen? Request a listing update